Maulana Muhammad Shafi, father of Abdussalam Puthige, passes away

Udupi, June 26: BJP leader K Raghavendra Kini has been appointed as the new Chairman of Udupi Urban Development Authority (UUDA) by Government of Karnataka.

A well-known businessman, Raghavendra Kini is also serving as the president of Kunjibettu Consumers’ Multipurpose Co-operative Union.

Along with him, the State Government has appointed Suma Naika, Praveen Kumar Shetty and Kishor Kumar as members of the Authority.

Karwar, June 29: The additional sessions court, Sirsi town police station and office of the deputy superintendent of police in Uttara Kannada district were sealed on Sunday after an undertrial was found positive for Covid-19.

The undertrial, accused of stealing a bike, from Hubballi was arrested by Sirsi police and had initially tested negative. He was confirmed infected when his samples were tested the second time.

He was arrested by Dharwad police in connection with a bike theft case. During interrogation it was found that he had stolen bikes in Sirsi too. Sirsi police had brought him from Dharwad sub-jail for the interrogation and was produced in the court.

The accused was in Manipal jail for some time after he was convicted there for the bike theft. While bringing him to Sirsi the police had wore PPE kits.

When he was produced in the court the judge had reportedly directed the police test him for covid as he had some symptoms.

His swab was collected and sent to the lab. In the first test the result was negative but it was positive in another test. At that time he was in Sirsi sub-jail. 10 police officials who had come into his contact have been quarantined. The police station has been sealed down and the court will be closed down on Monday and Tuesday.

All the under trails who were kept with him in the sub-jail have been isolated and their swab has been sent for the testing.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.